Cabot (NYSE:CBT) Raised to "Strong-Buy" at StockNews.com

Cabot (NYSE:CBT - Get Free Report) was upgraded by research analysts at StockNews.com from a "buy" rating to a "strong-buy" rating in a research note issued to investors on Wednesday.

CBT has been the topic of a number of other reports. Mizuho boosted their price objective on shares of Cabot from $104.00 to $109.00 and gave the company a "buy" rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft cut shares of Cabot from a "buy" rating to a "hold" rating and boosted their price target for the company from $88.00 to $95.00 in a report on Thursday, April 18th. Finally, UBS Group increased their price objective on Cabot from $100.00 to $103.00 and gave the stock a "neutral" rating in a report on Tuesday. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $93.67.

Cabot Stock Up 0.0 %

NYSE:CBT traded up $0.01 during trading hours on Wednesday, hitting $101.08. 425,901 shares of the stock traded hands, compared to its average volume of 309,793. The firm has a 50 day moving average price of $91.52 and a 200 day moving average price of $82.05. The firm has a market cap of $5.60 billion, a price-to-earnings ratio of 13.13, a PEG ratio of 1.00 and a beta of 1.27. Cabot has a fifty-two week low of $63.73 and a fifty-two week high of $103.46. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Monday, May 6th. The specialty chemicals company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.12. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.04 billion. During the same period in the previous year, the firm earned $1.33 earnings per share. Cabot's quarterly revenue was down 1.4% on a year-over-year basis. Equities research analysts anticipate that Cabot will post 6.58 earnings per share for the current year.

Insider Buying and Selling at Cabot

In other news, EVP Jeff Ji Zhu sold 55,233 shares of the company's stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the completion of the sale, the executive vice president now owns 97,201 shares in the company, valued at approximately $7,767,331.91. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.07% of the company's stock.

Institutional Trading of Cabot

A number of institutional investors and hedge funds have recently modified their holdings of CBT. Norges Bank bought a new position in Cabot in the 4th quarter worth $41,471,000. Sei Investments Co. increased its stake in shares of Cabot by 33.9% in the fourth quarter. Sei Investments Co. now owns 812,614 shares of the specialty chemicals company's stock worth $67,854,000 after purchasing an additional 205,582 shares during the period. Envestnet Asset Management Inc. lifted its position in shares of Cabot by 92.7% during the 3rd quarter. Envestnet Asset Management Inc. now owns 288,216 shares of the specialty chemicals company's stock worth $19,965,000 after purchasing an additional 138,663 shares during the last quarter. AQR Capital Management LLC grew its holdings in Cabot by 350.6% in the 3rd quarter. AQR Capital Management LLC now owns 176,452 shares of the specialty chemicals company's stock valued at $12,223,000 after buying an additional 137,294 shares during the last quarter. Finally, Eventide Asset Management LLC bought a new position in Cabot in the 4th quarter worth approximately $6,919,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.